Register entry

Takeda Pharmaceuticals Amercia, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
7
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

7

7 active NDC listings: 7 plasma derivative. By marketing category: BLA 7.

Dosage formNDCs
kit7
RouteNDCs
Labeller name on the listingNDCs
takeda pharmaceuticals amercia, inc.7
Catalogue

Marketed products

7
BrandGeneric nameForm / routeNDC
ADYNOVATEAntihemophilic Factor (Recombinant) PEGylatedkit0944-4622BLA
ADYNOVATEAntihemophilic Factor (Recombinant) PEGylatedkit0944-4623BLA
ADYNOVATEAntihemophilic Factor (Recombinant) PEGylatedkit0944-4624BLA
ADYNOVATEAntihemophilic Factor (Recombinant) PEGylatedkit0944-4625BLA
ADYNOVATEAntihemophilic Factor (Recombinant) PEGylatedkit0944-4626BLA
ADYNOVATEAntihemophilic Factor (Recombinant) PEGylatedkit0944-4627BLA
ADYNOVATEAntihemophilic Factor (Recombinant) PEGylatedkit0944-4628BLA
Enquiry

Common questions

Is Takeda Pharmaceuticals Amercia, Inc. FDA approved?
Takeda Pharmaceuticals Amercia, Inc. holds no registered establishment of its own; 7 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Takeda Pharmaceuticals Amercia, Inc. make?
7 products are listed under Takeda Pharmaceuticals Amercia, Inc. in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.